Gene · 2021
NIH grants944
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 944
Download this page as JSON| Grant | Title | ENDOG papers | Newest fiscal year |
|---|---|---|---|
| R01AI040646 | Non-canonical functions of autophagy proteins | 3 | 2023 |
| P50CA100707 | SPORE in Multiple Myeloma | 2 | 2023 |
| R01CA160417 | Mitophagy in Tumor Microenvironment | 2 | 2023 |
| I01BX004632 | The roles of the necroptotic and excitotoxic pathways in diisopropyl fluorophosphate-induced neuronal necrosis | 1 | 2023 |
| K08DC017508 | Tumor-Mediated Hearing Loss in Neurofibromatosis Type II | 1 | 2023 |
| P01HL114453 | Immunosuppression in Acute Lung Injury | 1 | 2023 |
| P20GM103641 | Dietary Supplements and Inflammation Phase-2: Isoxanthohumol as a treatment for estrogen-deficient-induced visceral hyperalgesia. | 1 | 2023 |
| R01AG010026 | Aging, Calorie Restriction and Insulin Sensitivity | 1 | 2023 |
| R01AG017917 | Epidemiologic Study of Neural Reserve and Neurobiology of Aging | 1 | 2023 |
| R01AG061798 | Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines | 1 | 2023 |
| R01AI020459 | Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity | 1 | 2023 |
| R01AI099708 | Interplay between the Endocrine and Innate Systems of Drosphila | 1 | 2023 |
| R01CA163649 | Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer | 1 | 2023 |
| R01CA211070 | The Pancreatic Cancer Microenvironment | 1 | 2023 |
| R01CA240984 | An antisense RNA-mediated regulatory program that drives cancer metastasis | 1 | 2023 |
| R01DA032444 | Effects of opiates on neurons and their impact on HIV neuropathology | 1 | 2023 |
| R01DK098414 | Mechanisms of Liver Regeneration After Acetaminophen-Induced Acute Liver Failure | 1 | 2023 |
| R01EY030499 | Antisense therapy for the treatment of visual loss in Usher syndrome | 1 | 2023 |
| R01HL150049 | Nitric oxide induced soluble guanylate cyclase dysfunction or activation: Implications as a disease indicator or in therapy | 1 | 2023 |
| R01MH119336 | Transduction of Psychological Stress into Systematic Inflammation by Mitochondrial DNA Signaling | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2021/grants?page=10